Press release
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market at 5.94% CAGR by 2031
Peptide Therapeutics Market
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of cancer and metabolic disorders such as osteoporosis, obesity and diabetes are expected to increase the use of peptide therapies in the coming years. The number of pediatric patients suffering from these diseases, widespread in low-income areas, need affordable supplies and effective drugs.
The market is expected to grow at a lucrative CAGR during the forecast period as companies focus on developing new drugs. Players have engaged in extensive research and development (R&D) activities to develop targeted therapies and increase their market share. Research and development in peptide therapeutics has focused on metabolism, followed by oncology and infectious diseases. Regulations for peptide therapies are seeing a shift toward more stringent requirements for efficacy, safety, and quality standards for approval. Regulatory agencies such as the FDA and EMA are actively developing new guidelines to refine the approval of peptide therapies.
Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/peptide-therapeutics-market
Business Verticals a Magnified Version of the Competitive Landscape in the Peptide Therapeutics Market
The competitive landscape in the peptide therapeutics market is characterized by interactions between established pharmaceutical giants, biotechnology companies and emerging players each with distinct competitive advantages.
Pharmaceutical Giants: The peptide therapeutics market is dominated by large pharmaceutical companies with huge investments in R&D and a global presence. Companies such as Eli Lilly, Novo Nordisk and Amgen are using their strong financial strength to develop broader peptide-based drugs, especially in areas such as diabetes and oncology.
Innovative research and development: Innovation in drug discovery and technology development is a key driver of competitiveness. Companies are investing heavily in new peptides that can be developed for specific diseases. For example, Eli Lilly's efforts to develop peptide-based drugs for diabetes, such as its breakthrough drug Trulicity, have helped secure a leading position.
For a tailored report, contact us to request a free customization: https://www.skyquestt.com/speak-with-analyst/peptide-therapeutics-market
Strategic Cooperation and Partnership
November 2022: Anterom developed one of the first immunotherapies based on its bacterial mimicry of drug recognition. Anterom reported safety, immunomodulatory, and efficacy data from its Phase 1/2 clinical trial of EO2401 in combination with an immune checkpoint inhibitor, for the treatment of patients with glioblastoma.
September 2022: Life science group Sartorius, through its French-listed subsidiary Sartorius StedimBiotech, acquired Albumedix Ltd. Albumedix is one of the leaders in recombinant albumin-based solutions.
This report covers following segments:
A. Application
Cancer
Metabolic
Cardiovascular Disorder
Respiratory
Gastrointestinal Diseases (GIT)
Anti-Infection
Pain
Dermatology
Central nervous system (CNS)
Renal
Others
B. Type of Manufacturers
In-house
Outsourced
C. Type
Generic
Innovative
D. Route of Administration
Parenteral
Oral
Pulmonary
Mucosal
Others
E. Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology
This report covers the following players:
Amgen, Inc.
AstraZeneca plc
Bachem Holding AG
Bristol-Myers Squibb Company
Eli Lilly and Company
Ipsen S.A.
Merck & Co., Inc.
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
Lonza Group AG
Ferring Pharmaceuticals, Inc.
PolyPeptide Group
Protagonist Therapeutics, Inc.
Ipsen Biopharmaceuticals, Inc.
Polytherapeutics Inc.
Zealand Pharma A/S
Purchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/peptide-therapeutics-market
Unlocking Future Potential in the Peptide Therapeutics Market
The peptide therapeutics market is poised for significant growth, driven by advances in drug delivery systems, increasing focus on precision medicine, expanding applications in oncology, metabolic disorders and infectious diseases. Peptides offer unique advantages such as high specificity and low toxicity, making them ideal for targeted therapies. With ongoing research, partnerships, and new technologies, the future of peptide therapies promises to deliver new treatments, improve patient outcomes, and be the next generation of medicine.
To read the full report, please visit: https://www.skyquestt.com/report/peptide-therapeutics-market
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=growing-adoption-of-synthetic-peptide-drugs-driving-peptide-therapeutics-market-at-594-cagr-by-2031]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/peptide-therapeutics-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market at 5.94% CAGR by 2031 here
News-ID: 3699224 • Views: …
More Releases from ABNewswire
VIP Auto PA: Auto Brokers Near Me Redefine Transparent Car Leasing in Feastervil …
VIP Auto PA continues serving Pennsylvania with transparent, factory-direct car leasing services from its Feasterville-Trevose location, offering zero-down options and no-haggle pricing across all vehicle makes and models.
Feasterville-Trevose, PA - The traditional car-buying experience has long frustrated consumers with high-pressure sales tactics and inflated pricing structures. VIP Auto PA [http://www.vipautopa.com/] continues addressing these industry pain points through a customer-centric brokerage model that has served Pennsylvania drivers since 2007. Operating from…
Austin Nail Salon Dream Spa Expands Service Menu with Apres Gel-X and Holistic W …
Dream Spa in Austin expands with Apres Gel-X nails, infrared sauna, and head spa treatments, offering comprehensive beauty and wellness services at its Airport Boulevard location near downtown Austin.
Dream Spa [https://www.dreamspaatx.com/], located at 5301 Airport Blvd, Suite 200 in Austin, Texas, has announced the expansion of its service offerings to include authentic Apres Gel-X nail extensions, infrared sauna therapy, and signature head spa treatments. The locally established business continues to…
Terrance Private Investigator Expands Houston Private Investigator Services with …
Terrance Private Investigator launches a Houston community program offering consultation, family case support, and professional investigation services to residents facing sensitive personal matters.
A Houston-based investigative firm is taking action to support families facing difficult personal situations. Terrance Private Investigator & Associates [https://piterrance.com/] has announced a new community initiative designed to provide accessible resources and confidential case consultations for residents throughout the Houston area.
The program addresses growing concerns among families facing…
El Monte Agency Strengthens Home Insurance Options and Community Protection Serv …
Marvin Martinez: Allstate Insurance strengthens El Monte's insurance options with bilingual services, comprehensive coverage, and community-focused customer education, earning Elite Agent recognition through consistent service excellence.
El Monte, California - The local insurance landscape continues to evolve as Marvin Martinez, of Allstate Insurance [https://agents.allstate.com/marvin-martinez-el-monte-ca.html?utm_source=GMB&utm_medium=Website], reinforces the company's commitment to protecting families and businesses throughout the San Gabriel Valley. The agency's focus on personalized coverage solutions has positioned it as a trusted…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
